A Critical Appraisal of the Oura Ring’s Stress, Resilience and Cumulative Stress Claims

Abstract

Background. Since 2023 the Oura Ring has offered three stress-related outputs. Daytime Stress labels minutes as stressed, engaged, relaxed or restored. Resilience grades the 14-day balance of stress and recovery on five levels from “limited” to “exceptional.” Cumulative Stress claims to reveal the “hidden toll” of chronic stress “before it manifests as fatigue, burnout, or illness.” Oura’s marketing invites users to “take charge of your stress” and “avoid burnout.” Its Chief Executive, in an interview the company filed with the US Securities and Exchange Commission (SEC), describes a device that can say “something’s really wrong” and prompt behaviour change.

Objective. To define what stress and resilience are and how they are measured, to establish what a finger-worn photoplethysmography (PPG), temperature and motion sensor can physiologically detect, and to appraise Oura’s claims to measure, predict and help remediate stress against the published evidence.

Findings. The ring’s inputs (heart rate, heart-rate variability, skin temperature and motion) index autonomic arousal, not stress. Arousal rises with psychological threat but equally with caffeine, alcohol, digestion, heat, posture, fever, dehydration, the luteal phase, many drugs and excitement. Oura itself acknowledges that the ring “can’t detect psychological stress.” Its own member data show that users who logged alcohol recorded about 50% more “stress” minutes, illustrating the non-specificity. No peer-reviewed validation of Daytime Stress or Resilience against a laboratory stressor, a cortisol reference or a validated resilience scale has been published. Cumulative Stress is supported by company-reported agreement with the Perceived Stress Scale or Copenhagen Burnout Inventory: 76% concordance in high scorers, 86% in low scorers and 82% overall. The development cohort, however, was recruited from people at the extremes of perceived stress, a design known to inflate diagnostic accuracy. The figures are not peer-reviewed and report no kappa, no calibration and no prediction of any clinical outcome. Resilience, a psychological capacity to adapt to adversity, is operationalised as a 14-day ratio of physiological load to recovery, partly built from a sleep score whose staging is itself weakly validated. On remediation, Oura does not claim to heal. We found no controlled trial showing that using the ring or its stress features reduces stress, prevents burnout or improves health. The study Oura cites tested a meditation app, had no control group and used the ring only as a measurement tool.

Conclusions. The Oura Ring measures arousal, not stress. It labels resilience without measuring it, and it cannot predict burnout or illness on any published evidence. Nor has it been shown to heal stress. Interventions with evidence, such as mindfulness-based programmes and structured heart-rate-variability biofeedback, exist independently of the ring. Clinicians should treat ring stress outputs as unvalidated wellness indicators. They should neither dismiss distress because the ring is reassuring nor attribute medical arousal to “stress” because the ring says so.

Keywords: stress; resilience; burnout; allostatic load; heart rate variability; autonomic nervous system; wearable devices; photoplethysmography; device validation; Oura Ring

1. Introduction

Stress is among the commonest reasons people give for buying a wearable, and among the hardest constructs in medicine to measure. Oura has built three features on it. Daytime Stress (October 2023) identifies “stress triggers by continuously measuring small changes in biometrics like heart rate, HRV, and temperature.”1 Resilience (January 2024) is “an estimate of your ability to withstand physiological stress and recover from it over time.”2 Cumulative Stress (October 2025) offers “an objective physiological signal” that is said to “reveal how the body manages and recovers from sustained stress” and to highlight “the often ‘hidden toll’ of unmanaged strain before it manifests as fatigue, burnout, or illness.”3 Oura’s product page tells consumers to “Take charge of your stress.” It says the features make it “easier to cope and overcome stressful moments” and that a long-term view of stress “allows you to prioritize balance and avoid burnout.”4

Three distinct claims are bundled here, and they require different evidence. A measurement claim says the ring detects stress. A predictive claim says it forewarns of burnout or illness. A remedial claim says that using it helps people reduce stress or become more resilient. This paper examines each in turn. It also examines the statements of Oura’s Chief Executive in an interview that the company filed with the SEC as part of its initial public offering.5

2. What stress and resilience are

2.1 Stress as a construct

Stress is not a single physiological quantity. In the allostatic model, a stressor is any challenge to homeostasis. The stress response is the coordinated activation of the sympathetic–adrenomedullary system and the hypothalamic–pituitary–adrenal axis. Chronic or repeated activation without adequate recovery produces allostatic load, the cumulative physiological cost associated with cardiovascular, metabolic and psychiatric disease.6 Psychological stress, in turn, is the appraisal that demands exceed one’s resources. It is measured by validated self-report instruments such as the Perceived Stress Scale (PSS).7 Burnout is a work-related syndrome of exhaustion, measured, for example, by the Copenhagen Burnout Inventory (CBI).8 These constructs overlap but are not interchangeable, and none is identical to autonomic arousal.

2.2 How stress is measured in research

Experimental stress research relies on standardised stressors with physiological reference measures. The Trier Social Stress Test is the best known: a combination of public speaking and mental arithmetic before an evaluative panel, with salivary cortisol and cardiovascular responses as outcomes.9 In ambulatory settings, the central methodological problem is that heart rate and its variability respond to physical activity and metabolic demand far more than to emotion. Valid inference about psychological stress therefore requires that the metabolic component be modelled and removed, for example as “additional heart rate” above that predicted by movement.10 Public multimodal datasets show that wrist sensors can classify a laboratory stressor against a resting baseline under controlled conditions, but generalisation to free living is substantially harder.11

2.3 Heart-rate variability and stress

Vagally mediated heart-rate variability (HRV) falls during acute stress and is lower, on average, in people under chronic stress. That association is supported by meta-analysis and by neuroimaging links between HRV and prefrontal regulation.12,13 At the level of the individual, however, HRV is determined by respiration, posture, age, sex, fitness, circadian phase, menstrual phase, alcohol, caffeine, illness and medication. Methodological guidance warns against interpreting it without controlling these factors.14–16 HRV declines steadily with age, and the luteal phase of the menstrual cycle lowers it.17,18 HRV is a sensitive index of autonomic state, but it is not a specific index of stress. Oura’s own educational material concedes that “HRV can show patterns linked to stress, but it cannot diagnose anxiety, depression, or another mental-health condition.”19

2.4 Resilience

Resilience is the capacity to adapt successfully to adversity. It is a multidimensional construct encompassing biological, psychological, social and contextual resources, assessed over time and in relation to actual adversity.20 Validated instruments include the Connor–Davidson Resilience Scale and the Brief Resilience Scale.21,22 Physiological recovery after a stressor is one plausible biological component of resilience, but it is not the construct itself.

3. What Oura claims

Table 1. Oura’s stress and resilience claims, with the evidence publicly available as at October 2026.

As with its other health features, Oura’s formal documentation is more careful than its marketing. The statement that the ring “can’t detect psychological stress” is accurate and should be credited.24 It sits uneasily, however, beside a product page promising to help users “avoid burnout” and a press release promising to reveal strain before it becomes “illness.”3,4

4. What the ring can physiologically detect

4.1 Arousal is not stress

Daytime Stress is computed from heart rate, HRV, motion and skin temperature during periods when the wearer is awake and “moderately stationary.”23 Each input changes with psychological stress, but each changes as much or more with other states (Table 2). The resulting label is best described as unexplained autonomic arousal: a departure from personal baseline that motion does not account for. To call it “stress” imports a psychological meaning that the signal cannot carry.

Table 2. Common causes of raised heart rate and reduced HRV during low-motion wakefulness that a ring would register as “stress.”

Oura’s own member data illustrate the problem. At the launch of Resilience, Oura reported that members averaged 92.6 minutes of “stress” per day, whereas those who mentioned alcohol averaged about 138.5 minutes. Stress minutes were also highest on Fridays and Saturdays.25 Alcohol raises heart rate and suppresses HRV for many hours pharmacologically, independently of psychological state. A metric that rises by about half after drinking, and peaks at weekends, is measuring physiology that includes intoxication, late nights and social activity. Some of that may be stressful, but much is not.

4.2 Movement and context

Restricting analysis to low-motion periods reduces but does not remove metabolic confounding. Posture, recent activity, digestion and thermal load still alter heart rate at rest.10 The ring has no information about context: whether a raised heart rate reflects an argument, a presentation, a cup of coffee or a febrile illness. Laboratory stress classifiers achieve their accuracy by comparing a known stressor with a known baseline.11 Free living provides neither.

4.3 Measurement accuracy is not construct validity

Oura’s nocturnal heart rate and HRV agree closely with electrocardiography. The company cites an r² of 0.98 for nocturnal measurements.19,27 That result concerns measurement of the input signal during sleep. It does not establish that daytime HRV, recorded under far noisier conditions, has been measured with the same accuracy. Nor does it establish that the derived label corresponds to stress. Accurate measurement of a non-specific variable remains non-specific.

5. Appraisal of the evidence

5.1 Daytime Stress

Oura states that the Daytime Stress algorithm “has been validated against other well-established solutions and by conducting surveys for users to study the alignment with their subjective estimation.”23 It names neither the reference solutions nor the sample size, design or metrics. We identified no peer-reviewed study validating the feature against a standardised laboratory stressor, against cortisol or against ecological momentary assessment. Without a disclosed reference standard and accuracy figures, the feature cannot be said to be validated in any sense a scientific reader would recognise.

5.2 Resilience

Resilience is computed over 14 days from three components: daytime stress load, daytime recovery and nighttime recovery. Nighttime recovery in turn draws on the sleep score, resting heart rate, HRV balance and a recovery index.2 The construct thus inherits all the non-specificity of Daytime Stress (Section 4). It also inherits the limitations of the ring’s sleep estimation, whose four-stage agreement with polysomnography in independent clinical samples is modest. We identified no validation of Resilience against the Connor–Davidson or Brief Resilience scales, against recovery from a standardised stressor, or against any outcome.21,22 The five labels, “Limited,” “Adequate,” “Solid,” “Strong” and “Exceptional,” are evaluative judgements on a person’s capacity to withstand adversity. They are derived from a ratio of non-specific physiological variables over two weeks and have no demonstrated relationship to that capacity.

5.3 Cumulative Stress

Cumulative Stress is the most substantive of the three features and the only one for which Oura has disclosed any validation figures. According to the company, the model was developed with the University of Southern Denmark in 151 volunteers “who reported high or low extremes of perceived stress.” It was then examined in more than 8,000 Oura Labs volunteers who completed the CBI and PSS monthly. Oura reports that “76% of those with high Cumulative Stress also reported an elevated CBI or PSS score,” that “86% of those with low CS also reported a low CBI or PSS score,” and that “overall, 82% of the CS results were in alignment with the CBI scores.”26 The five contributors are sleep continuity, heart stress-response, sleep micromotions, temperature regulation and activity impact. Their weighting is not disclosed.3,26 Five methodological points limit these figures.

1. Spectrum bias. Recruiting participants at the extremes of perceived stress removes the ambiguous middle of the distribution, where most people lie and where classification is hardest. Such designs are known to overstate diagnostic accuracy; in one empirical analysis, studies of this kind overstated the diagnostic odds ratio about threefold.28,29 The 76%, 86% and 82% figures may derive wholly or partly from this cohort or from extreme categories of the larger one; that is not clear from the report.
2. A union reference. “Elevated CBI or PSS” is a disjunctive reference standard. A positive result on either of two instruments is easier to match than a positive result on one, which inflates apparent concordance.
3. Percentage agreement without chance correction. Raw agreement must be compared with the agreement expected by chance. If high and low categories were evenly balanced, 82% agreement would correspond to Cohen’s kappa of 0.64. With a 30:70 split it would be 0.57. 30 These are moderate values, and the true marginals are not reported.
4. Concordance with a questionnaire is not detection of a physiological state. The reference instruments are self-report measures. If the ring merely re-expresses self-reported strain through sleep disruption, it adds little to asking the question. If it diverges, the questionnaire, not the ring, is the validated measure.
5. No outcome. The claim to reveal strain “before it manifests as fatigue, burnout, or illness”3 is a predictive claim. It requires a prospective study showing that Cumulative Stress forecasts incident burnout, sick leave or illness beyond what baseline questionnaires predict. Oura states only that chronic stress “has been associated with” disease. No such prediction has been reported.26 None of these results has been peer-reviewed. Taken at face value, they show moderate cross-sectional agreement between a physiological composite and self-reported stress in selected volunteers. That is a reasonable research finding. It does not amount to an “objective” measure of chronic stress, and it is not evidence of prediction.

6. Can the ring help heal stress?

Oura does not claim that the ring heals stress, and we found no statement to that effect. Its remedial language is softer: “take charge,” “make it easier to cope,” “build resilience” and “avoid burnout.”4 Each of these implies benefit. The relevant question is therefore whether using the ring, or its stress features and associated content, reduces stress or improves health compared with not using it.

We identified no randomised or otherwise controlled trial of that question. The study Oura has promoted in this context was a single-arm pilot in 20 pregnant women who practised mindfulness meditation with the Headspace app twice daily for a month.31 Perceived stress and anxiety fell, and low-frequency HRV recorded by the ring decreased. The intervention, however, was meditation. The ring served only as a measurement tool, there was no control group, the sample was small and homogeneous, and 45% of participants reported increased exercise.31 The study is evidence, of a preliminary kind, about meditation in pregnancy. It is not evidence that the ring reduces stress.

Effective interventions for stress do exist, and none depends on a ring. Mindfulness-based stress reduction has moderate effects on stress in healthy adults in meta-analysis.32 Structured HRV biofeedback, in which the user breathes at resonance frequency with real-time cardiac feedback, reduces self-reported stress and anxiety.33 Whether the guided sessions and content within Oura’s app reproduce the protocols tested in those trials has not been evaluated. Any benefit a user derives from them should be attributed to the behaviour, not to the measurement.

Monitoring can also cause harm. Clinicians have described “orthosomnia,” in which preoccupation with wearable sleep data worsens insomnia.34 A device that labels ordinary arousal as “stress,” grades a person’s resilience as “limited” and warns of a “hidden toll” has an obvious potential to amplify health anxiety. That possibility has not been studied.

7. The Chief Executive’s statements on the offering record

On 24 September 2026, Oura Inc. filed with the SEC an issuer free writing prospectus under Rule 433 (Registration Statement No. 333-298734; Accession No. 0001193125-26-401224). Exhibit A is the transcript of Robinhood’s Chief Executive interviewing Oura’s Chief Executive, Thomas Hale.5 A free writing prospectus may not conflict with the registration statement.35 Under FDA regulation, the statements of a manufacturer’s representatives are evidence of intended use.36 The interview does not name Daytime Stress, Resilience or Cumulative Stress. It does make statements about stress, behaviour change and the detection of abnormality that bear directly on them (Table 3).

Table 3. Statements in Exhibit A to Oura’s Rule 433 filing of 24 September 2026 bearing on stress and its remediation, quoted verbatim, with comment.5

The FDA’s January 2026 general wellness policy permits non-invasive physiological estimates for wellness, provided they do not imply clinical use.37 Stress management is a recognised wellness purpose. Claims to prevent “burnout” or “illness,” and a Chief Executive’s description of a device that recognises when “something’s really wrong,” move toward clinical territory. We express no legal conclusion. The scientific point is that claims of detection and prediction require evidence of detection and prediction.

8. Clinical implications

• Misattribution of medical arousal. Persistent tachycardia and low HRV labelled as “stress” may reflect hyperthyroidism, anaemia, infection, arrhythmia or medication. A patient who has accepted the ring’s label may present late.
• False reassurance in psychiatric illness. Depression, anxiety disorders and burnout are diagnosed clinically and with validated instruments. Normal ring metrics do not exclude them, and patients should not be told, or tell themselves, otherwise.
• Pathologising normal physiology. Exercise, sauna, sex, excitement and the luteal phase all generate “stress.” Grading a person’s resilience as “limited” on such inputs risks nocebo effects and health anxiety.34
• Misdirected effort. Users seeking relief may invest in monitoring rather than in interventions with evidence, such as structured mindfulness programmes, psychological therapy, HRV biofeedback, sleep and alcohol modification, and treatment of underlying conditions.32,33

9. Questions the manufacturer should answer

• The reference standard, sample, design and accuracy metrics for Daytime Stress, including performance against a standardised laboratory stressor and against ecological momentary assessment.
• How Daytime Stress distinguishes psychological stress from caffeine, alcohol, digestion, heat, the menstrual cycle, fever and medication, and the false-positive rate attributable to each.
• Any validation of Resilience against established resilience scales or against measured recovery from a standardised stressor.
• For Cumulative Stress: whether the published concordance figures derive from the extreme-recruited cohort, the full confusion matrix, Cohen’s kappa, performance in the middle of the stress distribution, and the contributor weights.
• Prospective evidence that Cumulative Stress predicts burnout, sick leave or illness beyond baseline questionnaires.
• Any controlled trial showing that use of the ring or its stress features reduces stress or improves health, and any study of adverse psychological effects.
• Performance by sex, age, and menstrual phase.

10. Recommendations

10.1 For clinicians

• Assess stress, anxiety, depression and burnout with clinical history and validated instruments (for example, PSS, GAD-7, PHQ-9, CBI), irrespective of ring outputs.7,8
• Investigate persistent resting tachycardia or reduced HRV on its merits before accepting a “stress” attribution.
• Recommend interventions with evidence, and do not regard ring use as a substitute for them.32,33
• Ask about distress caused by monitoring itself, and advise a break from the device where it is contributing.34

10.2 For users

• A “stressed” label means your body is aroused, not that you are distressed. Consider caffeine, alcohol, meals, heat, illness and your cycle before concluding otherwise.
• If you feel persistently overwhelmed, low or anxious, seek help even if the ring says you are “restored.”
• Use the data, if you find it helpful, to notice patterns, such as the effect of alcohol on your nights, but judge your wellbeing by how you feel and function.

10.3 For researchers and the manufacturer

• Publish peer-reviewed validation of each feature against an appropriate reference, with sex-stratified results.
• Use unselected, representative cohorts and chance-corrected agreement statistics.29,30
• Test predictive claims prospectively, and test remedial claims in randomised trials that include psychological harms as outcomes.

11. Conclusion

Stress is a psychological appraisal and a biological response. Its long-term cost, allostatic load, is mediated by many systems. A finger-worn ring measures heart rate, heart-rate variability, temperature and motion accurately enough at night, and those variables move with stress. They move equally with coffee, wine, meals, heat, fever, exercise, excitement and the menstrual cycle. Oura acknowledges that the ring “can’t detect psychological stress,” and that is correct. Its Daytime Stress and Resilience features have no published validation. Its Cumulative Stress feature shows moderate, chance-uncorrected agreement with self-report in a cohort recruited from the extremes, and no evidence of prediction. No controlled trial shows that the ring reduces stress, builds resilience or prevents burnout or illness. The Chief Executive’s filed account of a personal recovery is a testimonial, not evidence. On the published record, the Oura Ring can register arousal. It cannot measure, predict or heal stress, and it should not be presented as doing so.

Declarations

Author contributions: Bomi Joseph: Conceptualization, article conception and design, development of the manuscript outline, and writing of the manuscript.

Darshana Goakar: Research and investigation, source identification, collection of supporting documents, and compilation of the reference literature.

Both authors reviewed and approved the final manuscript.

Funding: This work was supported by Peak Health Center, San Francisco, California, USA (ROR: https://ror.org/04b23x642).

Competing interests: Bomi Joseph is the inventor of the Deep Health® Device, a health-measurement technology.

Darshana Goakar declares no competing interests.

Data availability

No new data were generated or analyzed specifically for this article. All data, figures, performance measures, and other quantitative information discussed in the manuscript derive from the publicly available sources cited in the article.

Use of artificial-intelligence tools

No artificial-intelligence tools were used in the research, analysis, preparation, or writing of this manuscript.

Note on sources

Descriptions of Oura products and features, and performance figures attributed to Oura, are derived from company publications, press releases, and other publicly available Oura materials current as of September 2026. Unless otherwise stated in the manuscript, these company-reported claims and figures have not been independently verified by the authors.

References

1. Oura Health Oy. ŌURA debuts stress management features and brushed titanium finish [press release]. Business Wire; 10 October 2023. Available from: https://www.businesswire.com/news/home/20231010693570/en
2. Oura Health Oy. Resilience [support article]. Available from: https://support.ouraring.com/hc/en-us/articles/25358829055251-Resilience
3. Oura Health Oy. ŌURA expands preventive health capabilities, empowering members to live better, longer [press release]. Business Wire; 20 October 2025. Available from: https://www.businesswire.com/news/home/20251020302425/en
4. Oura Health Oy. Oura Ring: advanced stress monitoring and stress management [product page]. Available from: https://ouraring.com/stress
5. Oura Inc. Issuer free writing prospectus filed pursuant to Rule 433, dated 24 September 2026, relating to preliminary prospectus dated 21 September 2026. Registration Statement No. 333-298734; SEC Accession No. 0001193125-26-401224. Exhibit A: transcript of Vlad Tenev’s interview of Thomas Hale, Chief Executive Officer.
6. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338(3):171–179.
7. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385– 396.
8. Kristensen TS, Borritz M, Villadsen E, Christensen KB. The Copenhagen Burnout Inventory: a new tool for the assessment of burnout. Work Stress. 2005;19(3):192–207.
9. Kirschbaum C, Pirke KM, Hellhammer DH. The ‘Trier Social Stress Test’: a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 1993;28(1–2):76–81.
10. Wilhelm FH, Grossman P. Emotions beyond the laboratory: theoretical fundaments, study design, and analytic strategies for advanced ambulatory assessment. Biol Psychol. 2010;84(3):552–569.
11. Schmidt P, Reiss A, Duerichen R, Marberger C, Van Laerhoven K. Introducing WESAD, a multimodal dataset for wearable stress and affect detection. In: Proceedings of the 20th ACM International Conference on Multimodal Interaction. 2018:400–408.
12. Kim HG, Cheon EJ, Bai DS, Lee YH, Koo BH. Stress and heart rate variability: a meta-analysis and review of the literature. Psychiatry Investig. 2018;15(3):235–245.
13. Thayer JF, Åhs F, Fredrikson M, Sollers JJ 3rd, Wager TD. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev. 2012;36(2):747–756.
14. Task Force of the European Society of Cardiology and the North American Society of Pacing and

Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93(5):1043–1065.

1. Quintana DS, Heathers JAJ. Considerations in the assessment of heart rate variability in biobehavioral research. Front Psychol. 2014;5:805.
2. Laborde S, Mosley E, Thayer JF. Heart rate variability and cardiac vagal tone in psychophysiological research: recommendations for experiment planning, data analysis, and data reporting. Front Psychol. 2017;8:213.
3. Umetani K, Singer DH, McCraty R, Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol. 1998;31(3):593–601.
4. Schmalenberger KM, Eisenlohr-Moul TA, Jarczok MN, et al. Menstrual cycle changes in vagally-mediated heart rate variability are associated with progesterone: evidence from two within-person studies. J Clin Med. 2020;9(3):617.
5. Oura Health Oy. HRV and stress: what HRV can tell you about your mental health. The Pulse Blog; 13 July 2023 (updated 30 September 2026). Available from: https://ouraring.com/blog/hrv-and-stress/
6. Southwick SM, Bonanno GA, Masten AS, Panter-Brick C, Yehuda R. Resilience definitions, theory, and challenges: interdisciplinary perspectives. Eur J Psychotraumatol. 2014;5:25338.
7. Connor KM, Davidson JRT. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76–82.
8. Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194–200.
9. Oura Health Oy. Inside the Ring: understanding Oura’s new Daytime Stress feature. The Pulse Blog; 21 November 2025. Available from: https://ouraring.com/blog/inside-the-ring-daytime-stress/
10. Oura Health Oy. Discover Oura’s Daytime Stress feature. The Pulse Blog; 3 October 2024 (updated 30 September 2026). Available from: https://ouraring.com/blog/daytime-stress-feature/
11. Oura’s latest feature helps you build mental strength and reduce stress. Tom’s Guide; 31 January 2024. Available from: https://www.tomsguide.com/wellness/fitness-trackers/ouras-latest-feature-helps-you-build-mental-strength-and-reduce-stress-heres-what-we-know
12. Oura Health Oy. Inside the Ring: Oura’s data-driven approach to quantifying chronic stress. The Pulse Blog; 19 December 2025. Available from: https://ouraring.com/blog/inside-the-ring-cumulative-stress/
13. Kinnunen H, Rantanen A, Kenttä T, Koskimäki H. Feasible assessment of recovery and cardiovascular health: accuracy of nocturnal HR and HRV assessed via ring PPG in comparison to medical grade ECG. Physiol Meas. 2020;41(4):04NT01.
14. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299(17):926–930.
15. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282(11):1061–1066.
16. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46.
17. Balsam D, Bounds DT, Rahmani AM, Nyamathi A. Evaluating the impact of an app-delivered mindfulness meditation program to reduce stress and anxiety during pregnancy: pilot longitudinal study. JMIR Pediatr Parent. 2023;6:e53933.
18. Khoury B, Sharma M, Rush SE, Fournier C. Mindfulness-based stress reduction for healthy individuals: a meta-analysis. J Psychosom Res. 2015;78(6):519–528.
19. Goessl VC, Curtiss JE, Hofmann SG. The effect of heart rate variability biofeedback training on stress and anxiety: a meta-analysis. Psychol Med. 2017;47(15):2578–2586.
20. Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? J Clin Sleep Med. 2017;13(2):351–354.
21. US Securities and Exchange Commission. Conditions to permissible post-filing free writing prospectuses. 17 CFR §230.433.
22. US Food and Drug Administration. Meaning of intended uses. 21 CFR §801.4.
23. US Food and Drug Administration. General wellness: policy for low risk devices. Guidance for industry and FDA staff. 6 January 2026.